FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathleen Propert

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Adenoviridae

Co-author Network

Publications

TOP 3
Sarah Sullivan; Stuart H Friess; Kathleen J Propert; Jill Ralston; Paul E Rapp; Colin Smith; Susan S Margulies
Behavioral deficits and axonal injury persistence after rotational head injury are direction dependent.
Marina Cuchel; Anna M E Du Plessis; Hendrik du Toit Theron; Daniel Gaudet; Robert A Hegele; A David Marais; Emma A Meagher; Kathleen J Propert; Daniel J Rader; Bill Sasiela; Prediman K Shah; Cesare R Sirtori; Claudia Stefanutti; Giovanni B Vigna; Maurizio R Averna; LeAnne T Bloedon; Dirk J Blom
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.
Jane Francisca Ferguson; Ram Gadi; Stephen R Master; Nehal N Mehta; Claire K Mulvey; Prabhjot S Nijjar; Parth N Patel; Kathleen J Propert; Rachana Shah; Rhia Y Shah; Haris M Usman; Muredach P Reilly
Race and gender variation in response to evoked inflammation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathleen Propert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah Sullivan; Stuart H Friess; Kathleen J Propert; Jill Ralston; Paul E Rapp; Colin Smith; Susan S Margulies
Behavioral deficits and axonal injury persistence after rotational head injury are direction dependent.
Journal of neurotrauma 2013;30(7):538-45.
2013: Marina Cuchel; Anna M E Du Plessis; Hendrik du Toit Theron; Daniel Gaudet; Robert A Hegele; A David Marais; Emma A Meagher; Kathleen J Propert; Daniel J Rader; Bill Sasiela; Prediman K Shah; Cesare R Sirtori; Claudia Stefanutti; Giovanni B Vigna; Maurizio R Averna; LeAnne T Bloedon; Dirk J Blom
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.
Lancet 2013;381(9860):40-6.
2013: Jane Francisca Ferguson; Ram Gadi; Stephen R Master; Nehal N Mehta; Claire K Mulvey; Prabhjot S Nijjar; Parth N Patel; Kathleen J Propert; Rachana Shah; Rhia Y Shah; Haris M Usman; Muredach P Reilly
Race and gender variation in response to evoked inflammation.
Journal of translational medicine 2013;11():63.
2012: Hualei Zhang; Jonathan A Epstein; Victor A Ferrari; Rachel S Frank; Bin Huang; Susan Margulies; Kathleen J Propert; Hui Qiao; Rong Zhou
Spin-labeling magnetic resonance imaging detects increased myocardial blood flow after endothelial cell transplantation in the infarcted heart.
Circulation. Cardiovascular imaging 2012;5(2):210-7.
2011: Christopher T Dibble; Victor A Ferrari; Richard A Kronmal; João A C Lima; Kathleen J Propert; R Graham Barr; David A Bluemke; Michael R Bristow; Harjit Chahal; Julio A Chirinos; Steven M Kawut
Regional left ventricular systolic function and the right ventricle: the multi-ethnic study of atherosclerosis right ventricle study.
Chest 2011;140(2):310-6.
2011: Debora R Sekiguchi; Jennifer A Sutter; Michael R Rickels; Ali Naji; Chengyang Liu; Kathleen J Propert; Wade T Rogers; Eline T Luning Prak
Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting.
Journal of immunological methods 2011;363(2):233-44.
2008: Yu-Xiao Yang; Sean Hennessy; Kathleen J Propert; Wei-Ting Hwang; Monika Sarkar; James D Lewis
Chronic statin therapy and the risk of colorectal cancer.
Pharmacoepidemiology and drug safety 2008;17(9):869-76.
2008: Kathleen J Propert; Robert Mayer; J Curtis Nickel; Christopher K Payne; Kenneth M Peters; Valerie Teal; David Burks; John W Kusek; Leroy M Nyberg; Harris E Foster
Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo.
The Journal of urology 2008;179(2):552-5.
2008: Daniel A Shoskes; Richard Berger; Angelo Elmi; J Richard Landis; Kathleen J Propert; Scott I Zeitlin
Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study.
The Journal of urology 2008;179(2):556-60.
2007: Susan K Keay; Jay E Reeder; Kristopher Koch; Chen-Ou Zhang; Daivd Grkovic; Kenneth Peters; Yawei Zhang; John W Kusek; Leroy M Nyberg; Christopher K Payne; Kathleen J Propert
Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).
World journal of urology 2007;25(5):499-504.
2007: Yu-Xiao Yang; Sean Hennessy; Kathleen J Propert; Wei-Ting Hwang; Alireza Sedarat; James D Lewis
Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Gastroenterology 2007;133(3):748-54.
2007: Kathleen J Propert; Robert Mayer; J Curtis Nickel; Christopher K Payne; Kenneth M Peters; Valerie Teal; David Burks; John W Kusek; Leroy M Nyberg; Harris E Foster
Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
The Journal of urology 2007;178(3 Pt 1):886-90.
2007: J Curtis Nickel; Dean A Tripp; Valerie Teal; Kathleen J Propert; David Burks; Harris E Foster; Philip Hanno; Robert Mayer; Christopher K Payne; Kenneth M Peters; John W Kusek; Leroy M Nyberg
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
The Journal of urology 2007;177(5):1832-6.
2007: Deborah R Erickson; Kathleen J Propert
Pregnancy and interstitial cystitis/painful bladder syndrome.
The Urologic clinics of North America 2007;34(1):61-9.
2007: Shaun Wen Huey Lee; Phaik Yeong Cheah; Shaun Lee; Kah Hay Yuen; Anthony J Schaeffer; Kathleen J Propert; John N Krieger
Demographic and clinical characteristics of chronic prostatitis: prospective comparison of the University of Sciences Malaysia Cohort with the United States National Institutes of Health Cohort.
The Journal of urology 2007;177(1):153-7; discussion 158.
2007: Benjamin E Leiby; J Richard Landis; Kathleen J Propert; John E Tomaszewski
Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system.
The Journal of urology 2007;177(1):142-8.
2006: J Curtis Nickel; Daniel A Shoskes; Yanlin Wang; Richard B Alexander; Jackson E Fowler; Scott I Zeitlin; Michael P O'Leary; Michel A Pontari; Anthony J Schaeffer; J Richard Landis; Leroy Nyberg; John W Kusek; Kathleen J Propert
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?
The Journal of urology 2006;176(1):119-24.
2006: Kathleen J Propert; Mark S Litwin; Y Wang; Richard B Alexander; Elizabeth A Calhoun; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton Collins
Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(2):299-305.
2006: Robert B Nadler; Mary McNaughton Collins; Kathleen J Propert; Stephen D Mikolajczyk; Jill S Knauss; J Richard Landis; Jackson E Fowler; Anthony J Schaeffer; Richard B Alexander
Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.
Urology 2006;67(2):337-42.
2006: Kathleen J Propert; Mary McNaughton Collins; Benjamin E Leiby; Michael P O'Leary; John W Kusek; Mark S Litwin
A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study.
The Journal of urology 2006;175(2):619-23; discussion 623.
2006: Kathleen J Propert; R D Mayer; Y Wang; Grannum R Sant; Philip Hanno; Kenneth M Peters; John W Kusek
Responsiveness of symptom scales for interstitial cystitis.
Urology 2006;67(1):55-9.
2006: Mary P FitzGerald; Colleen Brensinger; Linda Brubaker; Kathleen J Propert
What is the pain of interstitial cystitis like?
International urogynecology journal and pelvic floor dysfunction 2006;17(1):69-72.
2005: Leslie S Kersun; Kathleen J Propert; Ebbing Lautenbach; Nancy Bunin; Angela Demichele
Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
Pediatric blood & cancer 2005;45(2):162-9.
2005: Robert Mayer; Kathleen J Propert; Kenneth M Peters; Christopher K Payne; Yawei Zhang; David Burks; Daniel J Culkin; Ananias C Diokno; Philip Hanno; J Richard Landis; Rosemary Madigan; Edward M Messing; J Curtis Nickel; Grannum R Sant; John W Warren; Alan J Wein; John W Kusek; Leroy M Nyberg; Harris E Foster
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
The Journal of urology 2005;173(4):1186-91.
2005: Ajay K Israni; Harold I Feldman; Kathleen J Propert; Mary Leonard; Kevin C Mange
Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(2):374-82.
2005: Yuehui Wu; Valerii Fedorov; Kathleen J Propert
Optimal design for dose response using beta distributed responses.
Journal of biopharmaceutical statistics 2005;15(5):753-71.
2004: Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
Annals of internal medicine 2004;141(8):581-9.
2004: David J Margolis; Timothy Cromblehome; Meenhard Herlyn; Philip Cross; Linda Weinberg; Jennifer Filip; Kathleen J Propert
Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A.
Human gene therapy 2004;15(10):1003-19.
2004: Richard B Alexander; Dean L Mann; Andrew Borkowski; Marcelo Fernandez-Vina; Elena N Klyushnenkova; James Kodak; Kathleen J Propert; Marcie Kincaid
Granulomatous prostatitis linked to HLA-DRB1*1501.
The Journal of urology 2004;171(6 Pt 1):2326-9.
2003: J Curtis Nickel; Richard B Alexander; Anthony J Schaeffer; J Richard Landis; Jill S Knauss; Kathleen J Propert
Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.
The Journal of urology 2003;170(3):818-22.
2003: Grannum R Sant; Kathleen J Propert; Philip Hanno; David Burks; Daniel J Culkin; Ananias C Diokno; Christine Hardy; J Richard Landis; Robert Mayer; R Madigan; E M Messing; K Peters; T C Theoharides; John W Warren; A J Wein; William Steers; John W Kusek; Leroy M Nyberg
A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.
The Journal of urology 2003;170(3):810-5.
2003: Edward M Messing; Judith Manola; George Wilding; Kathleen J Propert; Jonathan Fleischmann; E David Crawford; J Edson Pontes; Richard Hahn; Donald Trump
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1214-22.
2003: Andrea N Leaf; Kathleen J Propert; Chris Corcoran; Paul J Catalano; Donald L Trump; Jules E Harris; Thomas E Davis
Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group study.
Medical oncology (Northwood, London, England) 2003;20(2):137-46.
2002: Kathleen J Propert; Christopher Payne; John W Kusek; Leroy M Nyberg
Pitfalls in the design of clinical trials for interstitial cystitis.
Urology 2002;60(5):742-8.
2002: Anthony J Schaeffer; Jill S Knauss; J Richard Landis; Kathleen J Propert; Richard B Alexander; Mark S Litwin; J Curtis Nickel; Michael P O'Leary; Robert B Nadler; Michel A Pontari; Daniel A Shoskes; Scott I Zeitlin; Jackson E Fowler; Carissa A Mazurick; John W Kusek; Leroy M Nyberg
Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.
The Journal of urology 2002;168(3):1048-53.
2002: C Norman Coleman; Laura Kelly; Nancy Riese Daly; Clair Beard; Irving Kaplan; Carolyn Lamb; Kathleen J Propert; Judith Manola
Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects.
International journal of radiation oncology, biology, physics 2002;54(1):191-4.
2002: Anthony J Schaeffer; J Richard Landis; Jill S Knauss; Kathleen J Propert; Richard B Alexander; Mark S Litwin; J Curtis Nickel; Michael P O'Leary; Robert B Nadler; Michel A Pontari; Daniel A Shoskes; Scott I Zeitlin; Jackson E Fowler; Carissa A Mazurick; Lori Kishel; John W Kusek; Leroy M Nyberg
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study.
The Journal of urology 2002;168(2):593-8.
2002: Robert A Lowe; Stephanie B Abbuhl; Agnieshka Baumritter; Colleen Brensinger; Kathleen J Propert; Steven C Horii; Harold L Kundel
Radiology services in emergency medicine residency programs: a national survey.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2002;9(6):587-94.
2002: Kathleen J Propert; Richard B Alexander; J Curtis Nickel; John W Kusek; Mark S Litwin; J Richard Landis; Leroy M Nyberg; Anthony J Schaeffer
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Urology 2002;59(6):870-6.
2002: Jason H T Karlawish; D A Casarett; Bryan D James; Kathleen J Propert; David A Asch
Do persons with dementia vote?
Neurology 2002;58(7):1100-2.
2002: Robert J Green; Joshua P Metlay; Kathleen J Propert; Paul J Catalano; John S Macdonald; Robert J Mayer; Daniel G Haller
Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089.
Annals of internal medicine 2002;136(4):261-9.
2002: Jason H T Karlawish; David Casarett; Kathleen J Propert; Bryan D James; Christopher M Clark
Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care.
Journal of geriatric psychiatry and neurology 2002;15(2):68-72.
2002: Steven E Raper; Marc Yudkoff; Narendra Chirmule; Guang-Ping Gao; Frederick Nunes; Ziv Haskal; Emma E Furth; Kathleen J Propert; Michael B Robinson; Susan Magosin; Heather Simoes; Lisa Speicher; Joseph Hughes; John Tazelaar; Nelson A Wivel; James M Wilson; Mark L Batshaw
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
Human gene therapy 2002;13(1):163-75.
2002: Michael A Schnell; Christine Hardy; Melanie Hawley; Kathleen J Propert; James M Wilson
Effect of blood collection technique in mice on clinical pathology parameters.
Human gene therapy 2002;13(1):155-61.
2001: Regina O Redfern; Robert A Lowe; Harold L Kundel; Steven C Horii; Kathleen J Propert; Stephanie B Abbuhl; Colleen Brensinger
From being a radiologist to watching a radiologist: impact of filmless operation on the training of radiology residents.
Academic radiology 2001;8(11):1154-8.
2001: H Tada; David J Maron; Eugene A Choi; James Barsoum; Hanqin Lei; Q Xie; W Liu; L Ellis; A David Moscioni; John Tazelaar; SE Fawell; X Qin; Kathleen J Propert; A Davis; Douglas L Fraker; James M Wilson; Francis R Spitz
Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
The Journal of clinical investigation 2001;108(1):83-95.
2001: ES Lambright; Kunjlata Amin; Rainer Wiewrodt; Seth Force; Michael Lanuti; Kathleen J Propert; Leslie A Litzky; Larry R Kaiser; Steven M Albelda
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
Gene therapy 2001;8(12):946-53.
2001: Stephen L Eck; Jane Alavi; Kevin D Judy; P Phillips; Abass Alavi; D Hackney; P Cross; J Hughes; Guangping Gao; James M Wilson; Kathleen J Propert
Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.
Human gene therapy 2001;12(1):97-113.
2000: Eric S Rovner; Kathleen J Propert; Colleen Brensinger; Alan J Wein; M Foy; Aaron Kirkemo; J Richard Landis; John W Kusek; Leroy M Nyberg
Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.
Urology 2000;56(6):940-5.
2000: Kathleen J Propert; A J Schaeffer; Colleen Brensinger; John W Kusek; Leroy M Nyberg; J Richard Landis
A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group.
The Journal of urology 2000;163(5):1434-9.
1999: Jonathan B Zuckerman; C B Robinson; K S McCoy; R Shell; Thomas J Sferra; Narendra Chirmule; Susan Magosin; Kathleen J Propert; E C Brown-Parr; JV Hughes; John Tazelaar; C Baker; M J Goldman; James M Wilson
A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
Human gene therapy 1999;10(18):2973-85.
1999: Narendra Chirmule; Kathleen J Propert; Susan Magosin; Y Qian; R Qian; J Wilson
Immune responses to adenovirus and adeno-associated virus in humans.
Gene therapy 1999;6(9):1574-83.
1999: J A Clark; PP Rieker; Kathleen J Propert; J A Talcott
Changes in quality of life following treatment for early prostate cancer.
Urology 1999;53(1):161-8.
1998: Clair Beard; C Lamb; L Buswell; L Schneider; Kathleen J Propert; D Gladstone; Anthony V D'Amico; Irving Kaplan
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.
International journal of radiation oncology, biology, physics 1998;41(2):257-62.
1998: J D Berlin; Kathleen J Propert; D Trump; G Wilding; Gary R Hudes; J Glick; P Burch; A Keller; Patrick J Loehrer
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889).
American journal of clinical oncology 1998;21(2):171-6.
1998: James A Talcott; PP Rieker; Jack A Clark; Kathleen J Propert; Jane C Weeks; Clair Beard; KI Wishnow; Irving Kaplan; K R Loughlin; Jerome P Richie; Philip W Kantoff
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):275-83.
1997: SB Saxman; Kathleen J Propert; Lawrence H Einhorn; E D Crawford; I Tannock; D Raghavan; Patrick J Loehrer; D Trump
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2564-9.
1997: Robert Dreicer; Kathleen J Propert; T Kuzel; J M Kirkwood; P J O'Dwyer; Patrick J Loehrer
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
American journal of clinical oncology 1997;20(3):251-3.
1997: Clair Beard; Kathleen J Propert; PP Rieker; Jack A Clark; Irving Kaplan; Philip W Kantoff; James A Talcott
Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):223-9.
1997: Robert Dreicer; Kathleen J Propert; B J Roth; L H Einhorn; Patrick J Loehrer
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).
Cancer 1997;79(1):110-4.
1996: Anthony V D'Amico; Kathleen J Propert
Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy.
International journal of radiation oncology, biology, physics 1996;35(2):273-9.
1994: Michael Seiden; Philip W Kantoff; K Krithivas; Kathleen J Propert; M Bryant; E Haltom; L Gaynes; Irving Kaplan; Glenn J Bubley; W DeWolf
Detection of circulating tumor cells in men with localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2634-9.
1993: Harvey Kreisman; A Lisbona; L Olson; Kathleen J Propert; C Modeas; Robert O Dillman; S L Seagren; Mark R Green
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer.
Cancer 1993;72(5):1588-96.
1993: S D Luikart; M Goutsou; E D Mitchell; David A Van Echo; C R Modeas; Kathleen J Propert; J O'Donnell; S Difino; M C Perry; M R Green
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B.
American journal of clinical oncology 1993;16(2):127-31.
1992: A P Lyss; M C Perry; M Goutsou; Kathleen J Propert; J E Herndon; K Mason-Coughlin; M R Green
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B.
American journal of clinical oncology 1992;15(5):399-404.
1992: Mark R Green; Harvey Kreisman; D C Doll; A P Lyss; G H Clamon; M Goutsou; M C Perry; Kathleen J Propert
Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experience.
Seminars in oncology 1992;19(1 Suppl 2):44-9.
1992: J B Hargis; J R Anderson; Kathleen J Propert; M R Green; David A Van Echo; Raymond B Weiss
Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B study.
Cancer chemotherapy and pharmacology 1992;30(4):291-6.
1992: M L Citron; C Modeas; Kathleen J Propert; M Goutsou; Mark R Green
Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
Cancer investigation 1992;10(3):215-9.
1992: Joseph Aisner; M Y Whitacre; D R Budman; Kathleen J Propert; G Strauss; David A Van Echo; M Perry
Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
Cancer chemotherapy and pharmacology 1992;29(6):435-8.
1990: Robert O Dillman; S L Seagren; Kathleen J Propert; J Guerra; W L Eaton; M C Perry; RW Carey; E F Frei; Mark R Green
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
The New England journal of medicine 1990;323(14):940-5.
1990: Q S Ringenberg; Kathleen J Propert; Hyman Muss; Raymond B Weiss; R L Schilsky; C Modeas; M C Perry; Larry Norton; M Green
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
Investigational new drugs 1990;8(2):221-6.
1989: A P Chahinian; Kathleen J Propert; J H Ware; B Zimmer; M C Perry; V Hirsh; A Skarin; S Kopel; James F Holland; R L Comis
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):993-1002.
1988: Q S Ringenberg; M C Perry; Kathleen J Propert; C Modeas; V Hirsh; Raymond B Weiss; F Richards; Stephen L Graziano; M Green
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.
Medical and pediatric oncology 1988;16(1):27-9.
1987: David J Kwiatkowski; Kathleen J Propert; RW Carey; Noah C Choi; M Green
A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(12):1874-9.
1987: H Kreisman; S Ginsberg; Kathleen J Propert; F Richards; S Graziano; M Green
Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study.
Cancer treatment reports 1987;71(11):1049-52.
1987: S D Luikart; Kathleen J Propert; C R Modeas; M R Green; M C Perry
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study.
Cancer treatment reports 1987;71(5):533-4.
1987: M C Perry; W L Eaton; Kathleen J Propert; J H Ware; B Zimmer; A P Chahinian; A Skarin; RW Carey; H Kreisman; C Faulkner
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.
The New England journal of medicine 1987;316(15):912-8.